Beta Bionics, Inc. (BBNX) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 1.23B |
| Enterprise Value | 1.21B |
| P/E Ratio | -9.86 |
| PEG Ratio | 8.03 |
| Price/Sales Ratio | 6.26 |
| Price/Book Ratio | 2.88 |
| Enterprise/Revenue | 5.95 |
| Enterprise/EBITDA | -9.86 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | -0.61 |
| Operating Margin | -0.7 |
AD
Management Effectiveness
| Return On Assets | -0.25 |
| Return On Equity | -0.26 |
Income Statement
| Revenue | 100.25M |
| Revenue/Share | 2.67 |
| Gross Profit | 55.54M |
| EBITDA | -70.32M |
| Net Income | -73.2M |
| Diluted EPS | -1.81 |
Balance Sheet
| Total Cash | 180.49M |
| Total Cash/Share | 4.05 |
| Total Debt | 6.51M |
| Total Debt/Equity | 0.03 |
| Current Ratio | 8.88 |
| Book Value Per Share | 5.76 |
Price History
| 52-Week Change | -34.61 |
| 52-Week High | 32.71 |
| 52-Week Low | 8.8 |
| Moving Average 50 Days | 17.24 |
| Moving Average 200 Days | 16.59 |
Statistics
| Average Volume | 1.15M |
| Shares Outstanding | 44.99M |
| % Held by Institutions | 108.55 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
